Literature DB >> 22644820

Aspergillus endocarditis in a native valve without prior cardiac surgery.

Keiichiro Kuroki1, Takashi Murakami.   

Abstract

Aspergillus native valve endocarditis continues to be a lethal disease, even when maximal therapeutic options are taken. We describe herein a patient with mitral valve endocarditis due to Aspergillus fumigatus following colon cancer and invasive pulmonary aspergillosis. Voriconazole was effective in controlling pulmonary and cerebral aspergillosis, despite the relative ineffectiveness for the vegetation. With the combination of aggressive medical and surgical therapy, the patient survived and remains without any evidence of infection 2 years later.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22644820     DOI: 10.1007/s11748-012-0076-5

Source DB:  PubMed          Journal:  Gen Thorac Cardiovasc Surg        ISSN: 1863-6705


  6 in total

1.  Aspergillus endocarditis: cure without surgical valve replacement.

Authors:  E G Maderazo; N Hickingbotham; B Cooper; A Murcia
Journal:  South Med J       Date:  1990-03       Impact factor: 0.954

2.  Successful treatment of Aspergillus prosthetic valve endocarditis with oral voriconazole.

Authors:  Lisa J Reis; Todd D Barton; Alberto Pochettino; Omaida Velazquez; Michael McGarvey; Bonnie Milas; Annette Reboli; Mindy G Schuster
Journal:  Clin Infect Dis       Date:  2005-07-20       Impact factor: 9.079

3.  Comparison of voriconazole (UK-109,496) and itraconazole in prevention and treatment of Aspergillus fumigatus endocarditis in guinea pigs.

Authors:  M V Martin; J Yates; C A Hitchcock
Journal:  Antimicrob Agents Chemother       Date:  1997-01       Impact factor: 5.191

4.  Aspergillus valve endocarditis in patients without prior cardiac surgery.

Authors:  T Gumbo; A J Taege; S Mawhorter; M C McHenry; B H Lytle; D M Cosgrove; S M Gordon
Journal:  Medicine (Baltimore)       Date:  2000-07       Impact factor: 1.889

5.  Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis.

Authors:  Raoul Herbrecht; David W Denning; Thomas F Patterson; John E Bennett; Reginald E Greene; Jörg-W Oestmann; Winfried V Kern; Kieren A Marr; Patricia Ribaud; Olivier Lortholary; Richard Sylvester; Robert H Rubin; John R Wingard; Paul Stark; Christine Durand; Denis Caillot; Eckhard Thiel; Pranatharthi H Chandrasekar; Michael R Hodges; Haran T Schlamm; Peter F Troke; Ben de Pauw
Journal:  N Engl J Med       Date:  2002-08-08       Impact factor: 91.245

Review 6.  Fungal endocarditis, 1995-2000.

Authors:  Lígia C Pierrotti; Larry M Baddour
Journal:  Chest       Date:  2002-07       Impact factor: 9.410

  6 in total
  3 in total

1.  Fungal mobile mass on echocardiogram: native mitral valve Aspergillus fumigatus endocarditis.

Authors:  Rymon Rofaiel; Yosra Turkistani; David McCarty; Seyed M Hosseini-Moghaddam
Journal:  BMJ Case Rep       Date:  2016-12-08

2.  Potential benefit of combination antifungal therapy in Aspergillus endocarditis.

Authors:  Kate Lennard; Aiveen Bannan; Peter Grant; Jeffrey Post
Journal:  BMJ Case Rep       Date:  2020-06-11

Review 3.  Histopathological implications of Aspergillus infection in lung.

Authors:  Naobumi Tochigi; Yoichiro Okubo; Tsunehiro Ando; Megumi Wakayama; Minoru Shinozaki; Kyoko Gocho; Yoshinobu Hata; Takao Ishiwatari; Tetsuo Nemoto; Kazutoshi Shibuya
Journal:  Mediators Inflamm       Date:  2013-11-20       Impact factor: 4.711

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.